Despite therapeutic advances that have changed the landscape of rheumatoid arthritis treatment over the past decade, work disability rates among RA patients remain “unacceptably high,” says Dr. Tuulikki Sokka. Diana Mahoney of the Global Medical News Network (GMNN) reports from the annual European Congress of Rheumatology.

Share

Tagged with:

Filed under: Arthritis

Like this post? Subscribe to my RSS feed and get loads more!